Fuse Medical, Inc., (OTC: FZMD), (“Fuse” or the “Company”), a contract manufacturer and national distributor of medical devices, announced that it has been named Number 56 on Deloitte’s 2018 Technology Fast 500TM (“Technology Fast 500TM”), an annual ranking of the fastest growing North American companies in the technology, media, telecommunications, life sciences and energy tech…
Fuse Medical, Inc., (OTC: FZMD), (“Fuse” or the “Company”), announced that it has filed its quarterly report on Form 10-Q for the third quarter ended September 30, 2018 of the Fiscal Year 2018 with the United States Securities and Exchange Commission, (the “SEC”) on Tuesday November 13, 2018. The Company’s third quarter results reflect the…
Fuse Medical, Inc. (OTC: FZMD) (“Fuse” or the “Company”), announced the completion of the acquisition of Palm Springs Partners, LLC d/b/a Maxim Surgical (“Maxim”), a manufacturing company in the spinal fusion device market and fullservice medical device and distribution company (the “Acquisition”). The effective date of Acquisition was August 1, 2018. Formed in April 2011,…
Fuse Medical, Inc., (OTC: FZMD), (“Fuse” or the “Company”), announced that it has filed its quarterly report on Form 10-Q for the first quarter ended March 31, 2018, with the United States Securities and Exchange Commission, (the “SEC”) on Tuesday May 15, 2018. Christopher C. Reeg, Chief Executive Officer, commented, “We are pleased to report…
Fuse Medical, Inc., (OTC: FZMD), (“Fuse” or the “Company”), announced the appointment of Montgomery, Coscia, Greilich, LLP, (“MCG”), headquarter in Plano, Texas as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017. The Company’s Board of Directors and management believe that MCG’s size and expertise more closely align with…
RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc., (OTC: FZMD), (“Fuse” or the “Company”), announced the appointment of Montgomery, Coscia, Greilich, LLP, (“MCG”), headquarter in Plano, Texas, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017. The Company’s Board of Directors and management believe that MCG’s size and expertise more closely…
Fuse Medical, Inc., (OTC: FZMD), (“Fuse” or the “Company”), announced the completion of the acquisition of CPM Medical Consultants, LLC (“CPM”), a privately-owned nationwide distributor of medical device implants and biologics, (the “Acquisition”). The effective date of closing was December 31, 2017. Following the completion of the Acquisition, CPM operates as a wholly-owned subsidiary of…
Fuse Medical, Inc., (OTC: FZMD), (“Fuse” or the “Company”), announced today that it signed a definitive purchase agreement to acquire CPM Medical Consultants, LLC (“CPM”), a privately-owned nationwide distributor of medical device implants and biologics. CPM is a stocking distributor with an extensive portfolio of orthopedic implants for total joint reconstruction, sports medicine, internal and…
Fuse Medical, Inc. (OTC: FZMD) (“Fuse” or the “Company”) announced today that it signed a non-binding Letter of Intent (“LOI”) to purchase all of the outstanding membership units of CPM Medical Consultants, LLC (“CPM”), a privately-owned national distributor of medical device implants and biologics. CPM is a stocking distributor with a broad portfolio of orthopedic…
Fuse Medical, Inc. (OTC: FZMD) (“Fuse” or the “Company”) announced today that it closed on a capital investment from local healthcare executives Mark W. Brooks and Christopher C. Reeg. Messrs. Brooks and Reeg bring over 50 years of combined experience in the ancillary healthcare market and have partnered in the formation and operation of multiple…